DEMANT Demant A/S

CPH · DK · Healthcare · Medical Devices · demant.com

319.20DKK+1.66%Mkt Cap: 9.81B $P/E: 27.80Today

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hea…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

$10.15BUSDP/E 19.3

BIO

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

BRKR

Bruker Corporation - Common Stock

$9.64BUSD

Key Statistics

Company

Market Cap9.81B USD

Enterprise Value12.40B USD

Revenue (TTM)3.59B USD

Gross Profit2.53B USD

Net Income (TTM)225.03M USD

Revenue/Share116.71 DKK

Last Price319.20 DKK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees26.6K

CountryDK

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)27.80

P/E (Forward)19.70

PEG1.38

EV/EBITDA17.12

EV/Revenue3.46

P/S2.69

P/B5.89

EPS (TTM)11.48

EPS (Forward)15.94

52W Range

175.0099% of range321.20

52W High321.20 DKK

52W Low175.00 DKK

Profitability

Gross Margin75.62%

Oper. Margin16.53%

EBITDA Margin20.19%

Profit Margin6.73%

ROE15.70%

ROA3.95%

Growth

Revenue Growth14.80%

Earnings Growth6.40%

Cash Flow & Leverage

Operating CF561.05M USD

CapEx (TTM)124.82M USD

FCF Margin15.26%

FCF Yield5.58%

Net Debt2.74B USD

Net Debt/EBITDA3.78

Balance Sheet

Debt/Equity2.13

Current Ratio0.82

Quick Ratio0.53

Book Value/Sh53.27 DKK

Cash/Share7.09 DKK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 DKK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateApr 26, 2000

Pay Date—

Splits

Last Split5:1

Split DateMay 25, 2016

Analyst Consensus

Rating2.1 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)302.55 DKK

Upside (mean)-5.2%

Target Range220.00 DKK – 388.00 DKK

220.00-5.2% to mean388.00

# Analysts20

Ownership

Shares Out.210.90M

Float83.83M

Insiders60.00%

Institutions18.52%

Technical

SMA 50293.50 (+8.8%)

SMA 200240.34 (+32.8%)

Beta0.76

S&P 52W Chg14.58%

Avg Vol (30d)254.90K

Avg Vol (10d)272.63K

Technical Indicators

RSI (14)63.0

MACD6.7778

MACD Signal6.1669

MACD Hist.+0.6109

BB Upper321.79 DKK

BB Middle303.19 DKK

BB Lower284.59 DKK

BB Width12.27%

ATR (14)6.872 DKK

Vol Ratio (20d)0.88x